Kyotorphin has a novel action on rat cardiac muscle

Biochem Biophys Res Commun. 2006 Jan 20;339(3):805-9. doi: 10.1016/j.bbrc.2005.11.081. Epub 2005 Nov 22.

Abstract

Several endogenous peptides for G-protein-coupled receptors have been found to play physiological roles in muscle contraction in addition to their well-demonstrated actions in other tissues. To further identify such peptides, we screened over 400 peptides using an isometric tension assay of rat papillary muscle. Here, we report that kyotorphin, which is known as an analgesic dipeptide, has a cardiac effect. Although kyotorphin had no effect on the twitch tension itself, it inhibited beta-adrenergic agonist isoprenaline-induced increases in twitch tension in a dose-dependent manner. Leu-Arg, a selective antagonist of kyotorphin, reversed this inhibitory effect. The inhibitory effect was also reversed by naloxone, an opioid receptor antagonist. These results suggest that kyotorphin may release opioid peptides from rat cardiac muscle and have an indirect regulatory role in beta-adrenergic action through cross-talk with opioid receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Endorphins / administration & dosage*
  • In Vitro Techniques
  • Isometric Contraction / drug effects
  • Isometric Contraction / physiology*
  • Isoproterenol / administration & dosage*
  • Male
  • Myocardial Contraction / drug effects
  • Myocardial Contraction / physiology*
  • Papillary Muscles / drug effects
  • Papillary Muscles / physiology*
  • Rats
  • Rats, Wistar

Substances

  • Drug Combinations
  • Endorphins
  • kyotorphin
  • Isoproterenol